• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Emergency Preparedness and Response

  • Print
  • Share
  • E-mail

Extramural Research

Laboratory equipment with small screen reading “Ready”In addition to intramural research, FDA has established a robust extramural research portfolio under the Medical Countermeasures Initiative (MCMi) regulatory science program.


Alignment with U.S. MCM priorities

To ensure that funded research aligns with Public Health Emergency Medical Countermeasures Enterprisedisclaimer icon priorities, FDA established a Steering Committee for Advancing MCMi Regulatory Science.

Representatives evaluate MCMi Regulatory Science Program research proposals for scientific/technical merit and feasibility and alignment with U.S. MCM priorities. In addition to FDA, members include:

  • National Institutes of Health (NIH)
  • Centers for Disease Control and Prevention (CDC)
  • Biomedical Advanced Research and Development Authority (BARDA)
  • U.S. Department of Defense (DoD)


Extramural medical countermeasure (MCM) regulatory science is primarily funded through a Broad Agency Announcement (BAA), which is currently accepting responses until May 22, 2014.

Learn more about the BAA and view currently funded programs